Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
SUBLOCADE™
(buprenorphine extended-release) Injection for Subcutaneous Use (CIII)
Please
click
for full Prescribing Information, including Boxed Warning.
You are here
Home
News by month %2 2014
News by month November 2014
PTCommunity News November 2014
New Device May Ease Mammography Discomfort
Psoriasis Treatment Brodalumab Shows Promise in Pivotal Study
FDA Postpones Review of Multiple Myeloma Compound Panobinostat
CDC Report: Only 30% of Americans With HIV Have Virus in Check
Genentech Defends Supply Shift for Top Cancer Drugs
FDA Warns Against Using Laparoscopic Power Morcellators to Treat Uterine Fibroids
Powdered Measles Vaccine Found Safe in Early Trial
Task Force Finds Insufficient Evidence on Screening for Vitamin D Deficiency in Adults
Report: Tecfidera Becoming Key Player on MS Scene
FDA Approves Onexton Gel for Treatment of Acne Vulgaris
Positive Pivotal Trial Data Reported for Patiromer FOS in Treatment of Hyperkalemia
Scientists Develop Noninvasive Test for Endometriosis
Amgen Terminates All Clinical Studies of Rilotumumab in Advanced Gastric Cancer
FDA Grants ‘Breakthrough Therapy’ Designation to T-Cell Treatment for Leukemia
Experts Dispute Claims of Looming Doctor Shortage
With New Study, Personalized Cancer Vaccines Edge Closer to Reality
FDA Approves Abuse-Deterrent Hydrocodone Pill
Report: Economic Burden of Diabetes Up 48% Over 5 Years
Nanoparticle RSV Vaccine Wins ‘Fast Track’ Designation
New Device Reduces Scarring in Damaged Blood Vessels
Daily Hydroxyurea Therapy Safe and Effective in Children With Sickle Cell Anemia, Authors Say
Report: First Class of Biosimilars to Enter U.S. Market Could Generate $1.8 Billion in Sales by 2023
Encouraging Results Reported for Ovarian Cancer Drug Rucaparib
Dupilumab Receives ‘Breakthrough Therapy’ Designation for Atopic Dermatitis
Costly Hepatitis C Treatments Help Drive 12% Drug Spending Jump
FDA Puts Partial Hold on Clinical Trials of Cancer Drug Aldoxorubicin
Oral Apremilast (Otezla) Shows Sustained Clinical Response in Patients With Active Psoriatic Arthritis
Study: Common Blood Pressure Drugs Do Not Increase Risk of Breast Cancer
New Drug Application Submitted to FDA for 3-Month Paliperidone Palmitate (Invega Sustenna) for Schizophrenia
Alirocumab Reduces LDL Cholesterol in Six Phase III Trials
Gallup Poll: Ebola Ranks Among Americans’ Top Three Health Care Concerns
Two Drugs Are No More Effective Than One to Treat Common Kidney Disease
New Fibromyalgia Treatment Shows Promise in Mid-Stage Study
Portable Electrical Device Slows Growth of Deadliest Brain Cancer
Report: U.S. Radiology Departments Prepare for Ebola
MS Treatment Alemtuzumab (Lemtrada) Gets FDA Green Light
Secukinumab Shows Symptom Improvement in Pivotal Arthritis Studies
Blood Test Could Prevent Medication Trial and Error for RA Patients, Mayo Clinic Says
FDA Approves Bevacizumab (Avastin) Plus Chemotherapy for Type of Ovarian Cancer
Sierra Leone Doctor Dies of Ebola at Nebraska Hospital
Survey: Ulcerative Colitis Drug Market Will Grow Over Next Decade
New ‘Guiding Principles’ for Diabetes Care
Genetic Testing Could Improve Breast Cancer Prevention, Authors Say
AstraZeneca Developing Reversal Agent for Its Own Heart Drug, Brilinta (Ticagrelor)
FDA Approves Once-Monthly Invega Sustenna (Paliperidone Palmitate) for Schizoaffective Disorder
Brodalumab Superior to Ustekinumab (Stelara) in Pivotal Psoriasis Study
Ebola Preparedness Training Available Online
Researchers Studying Blood Test That Could Reduce Antibiotic Use
Study: Baby Boomers Will Drive Explosion in Alzheimer’s-Related Costs in Coming Decades
Medical Centers Ask Congress to Probe Change in Distribution of Key Cancer Drugs
FDA Accepts Application for LDL Cholesterol-Lowering Drug Evolocumab
Dartmouth Report: Lung Cancer Screening With Low-Dose CT Could Be Cost-Effective
Studies Show Beta-Blockers Have No Mortality Benefit in Post-Heart Attack Patients
Opioid Overdoses Responsible for About 136,000 Emergency Visits in 2010
Asthma Patients to Docs: Can We Talk About Cost?
FDA Blasts Company for Sleep Drug Ad
In Surprise Move, Supreme Court Will Examine Key Part of Affordable Care Act
FDA Panel Says ‘No’ to Multiple Myeloma Compound Panobinostat
Hepatitis C Triple Combo Scores Big in Phase III Trials
CDC Report: U.S. Skin Cancer Costs Rise in 2002–2011
Bio-Filtration Device Helps Eradicate Virus in Ebola Patient
Drug for Nonalcoholic Steatohepatitis Shows Promising Results
Report: Pneumonia Vaccine Reduces Pediatric Admissions
U.S. Specialists Applaud Harvoni, First Single-Tablet Regimen for HCV Infections
New Drug Application Submitted to FDA for Single-Tablet HIV Regimen
Ramucirumab/Paclitaxel Combo Approved for Gastric Cancer
WHO Issues Update on Ebola Crisis
FDA Rejects Growth Hormone Test
Simeprevir/Sofosbuvir Combo Gets FDA Nod as All-Oral Treatment for Hepatitis C Infection
Hospital Medical Errors Reduced 30% With Improved Patient Handoffs
Ovarian Cancer Drug Trebananib Fails to Improve Overall Survival
Positive Results Reported From Mid-Stage Trial of Cabozantinib (Cometriq) and Erlotinib (Tarceva) in Lung Cancer Patients
Cystic Fibrosis Combo Lumacaftor/Ivacaftor Submitted for FDA Review
Scientists Develop New Way to Kill Bacteria
FDA Advisors Question Study Data Submitted for Dialysis Therapy
Aripiprazole Superior to Paliperidone Palmitate in Improving Quality of Life for Schizophrenia Patients
Survey: Diabetic Nephropathy Considered Renal Disease With Greatest Unmet Need for New Treatments
Nine Out of 10 Obese Adults Lose Weight With Liraglutide in Phase III Trial
Report: Undiagnosed Chagas Disease Emerging as U.S. Public Health Threat
First Guidelines on Use of Complementary Therapies for Breast Cancer
FDA Removes Full Clinical Hold on Imetelstat
Promising Mid-Stage Data Reported for HIV Drug Doravirine
New Findings Support Safety and Efficacy of Dabigatran (Pradaxa) for Atrial Fibrillation
FDA Expands Labeling for Fluzone High-Dose Vaccine for Adults 65 and Older
Report: Nasal Spray Vaccine May Offer Long-Lasting Protection From Ebola Virus
